Lv42
410 积分 2024-03-28 加入
Identification of a Novel HIV-1 Second-Generation Circulating Recombinant Form (CRF117_0107) in China
3天前
已完结
Phylogenetic Analysis of Sequences in the HIV Database Revealed Multiple Potential Circulating Recombinant Forms in China
25天前
已完结
Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 Years
1个月前
已关闭
A case of lenacapavir use for preventing mother-to-child HIV transmission
1个月前
已完结
The long shot
2个月前
已完结
Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy with Lenacapavir-Containing Regimen
2个月前
已完结
Lenacapavir: A novel injectable HIV-1 capsid inhibitor
2个月前
已完结
Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial
2个月前
已完结
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial
2个月前
已完结
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study
2个月前
已完结
皖公网安备34019202002308
